These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 26255596
1. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone. Johnson RW, McGregor NE, Brennan HJ, Crimeen-Irwin B, Poulton IJ, Martin TJ, Sims NA. Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596 [Abstract] [Full Text] [Related]
2. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation. Johnson RW, Brennan HJ, Vrahnas C, Poulton IJ, McGregor NE, Standal T, Walker EC, Koh TT, Nguyen H, Walsh NC, Forwood MR, Martin TJ, Sims NA. J Bone Miner Res; 2014 Jun; 29(6):1492-505. PubMed ID: 24339143 [Abstract] [Full Text] [Related]
4. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells. Ruiz P, Martin-Millan M, Gonzalez-Martin MC, Almeida M, González-Macias J, Ros MA. Sci Rep; 2016 Nov 02; 6():36201. PubMed ID: 27804995 [Abstract] [Full Text] [Related]
6. Interleukin-11 receptor signaling is required for normal bone remodeling. Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L, Martin TJ. J Bone Miner Res; 2005 Jul 02; 20(7):1093-102. PubMed ID: 15940362 [Abstract] [Full Text] [Related]
7. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. Sims NA. Int J Biochem Cell Biol; 2016 Oct 02; 79():14-23. PubMed ID: 27497989 [Abstract] [Full Text] [Related]
12. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines. O'Brien CA, Lin SC, Bellido T, Manolagas SC. J Cell Biochem; 2000 Sep 14; 79(4):532-41. PubMed ID: 10996844 [Abstract] [Full Text] [Related]
13. Cortical bone maturation in mice requires SOCS3 suppression of gp130/STAT3 signalling in osteocytes. Walker EC, Truong K, McGregor NE, Poulton IJ, Isojima T, Gooi JH, Martin TJ, Sims NA. Elife; 2020 May 27; 9():. PubMed ID: 32458800 [Abstract] [Full Text] [Related]
14. Osteoclasts are present in gp130-deficient mice. Kawasaki K, Gao YH, Yokose S, Kaji Y, Nakamura T, Suda T, Yoshida K, Taga T, Kishimoto T, Kataoka H, Yuasa T, Norimatsu H, Yamaguchi A. Endocrinology; 1997 Nov 27; 138(11):4959-65. PubMed ID: 9348227 [Abstract] [Full Text] [Related]
15. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts. Ucer S, Iyer S, Bartell SM, Martin-Millan M, Han L, Kim HN, Weinstein RS, Jilka RL, O'Brien CA, Almeida M, Manolagas SC. J Bone Miner Res; 2015 Jul 27; 30(7):1138-49. PubMed ID: 25704845 [Abstract] [Full Text] [Related]
16. gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice. Sims NA. Mol Cell Endocrinol; 2009 Oct 30; 310(1-2):30-9. PubMed ID: 18805458 [Abstract] [Full Text] [Related]
19. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice. Li M, Pan LC, Simmons HA, Li Y, Healy DR, Robinson BS, Ke HZ, Brown TA. Bone; 2006 Oct 30; 39(4):796-806. PubMed ID: 16759917 [Abstract] [Full Text] [Related]
20. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice. Cheon YH, Kim JY, Baek JM, Ahn SJ, Jun HY, Erkhembaatar M, Kim MS, Lee MS, Oh J. J Bone Miner Res; 2016 Feb 30; 31(2):403-15. PubMed ID: 26255791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]